Chubb Ltd vs Revvity Inc — how do they compare? Chubb Ltd trades at $347 (market cap $134.37B), while Revvity Inc trades at $115.76 (market cap $12.94B). The key difference: Chubb Ltd is far larger — about 10.4× Revvity Inc's market cap, and Chubb Ltd pays the higher dividend (1.17%). Which is the better fit depends on your goals.
| CB | RVTY | |
|---|---|---|
Market Cap | $134.37B | $12.94B |
Sector | Financials | Technology |
52-Week High | $363.50 | $117.75 |
52-Week Low | $268.20 | $82.26 |
Enterprise Value | $155.22B | $15.26B |
Dividend Yield | 1.17% | 0.24% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $114.66, up 0.37% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust fundamentals with a 54.98% gross margin and $241.20M net income for 2025, supported by positive news including product launches and raised 2026 guidance. Analyst consensus is a buy with a $120.50 price target, indicating potential upside from current levels.
Outlook remains positive due to consistent earnings outperformance and innovation in diagnostics, but risks include high P/E valuation and competitive pressures. Investors may find opportunity in sustained margin strength and AI integration, though macroeconomic sensitivity warrants caution.
Trailing returns across standard periods
ACE acquired Chubb in the first quarter of 2016 and assumed the Chubb name. The combination makes the new Chubb one of the largest domestic property and casualty insurers, with operations in 54 countries spanning commercial and personal P&C insurance, reinsurance, and life insurance.
Read more on CB →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →